Ignite Creation Date:
2024-05-05 @ 12:02 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00229710
Status:
TERMINATED
Last Update Posted:
2010-11-19
First Post:
2005-09-28
Brief Title:
GALLEX 9 Safety and Tolerability of Oral Tesaglitazar When Added to Insulin Therapy in Patients With Type 2 Diabetes
Sponsor:
Organization:
AstraZeneca